Future of Generics The Falsified Medicines Directive – truly an opportunity for... Telling the fake from the true is often a challenge, particularly in this era of ‘fake news’.
News Bayer hits "turning point" in recovery plan, says CEO Bayer's pharma unit has reached a "turning point" in its growth trajectory as sales of new medicines rose 6.4% in Q3, says CEO Bill Anderson.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
